View of In Silico Study of Imidazole-Morpholine-1,2,4-Oxadiazole Derivatives as Candidate Breast Cancer Drugs via Molecular Docking Targeting ER-α, ADMET Analysis and Drug-Likeness Assessment

Return to Article Details In Silico Study of Imidazole-Morpholine-1,2,4-Oxadiazole Derivatives as Candidate Breast Cancer Drugs via Molecular Docking Targeting ER-α, ADMET Analysis and Drug-Likeness Assessment Download Download PDF